Ignite Creation Date:
2025-12-25 @ 3:07 AM
Ignite Modification Date:
2026-01-09 @ 3:02 AM
Study NCT ID:
NCT01561833
Status:
COMPLETED
Last Update Posted:
2020-08-13
First Post:
2012-03-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Pilot Study of Sorafenib Examining Biomarkers in Refractory or Relapsed T-Cell Lymphoma Patients
Sponsor:
Yale University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
0901004690
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None